Feldan - About the company
Feldan is a series B company based in Quebec City (Canada), founded in 2007. It operates as a Developing delivery system of proteins inside cells directly. Feldan has raised $52.9M in funding from investors like Fonds de solidarite FTQ, Amgen and Invest Quebec. The company has 2004 active competitors, including 475 funded and 359 that have exited. Its top competitors include companies like Synthego, Sutro Biopharma and Avidity Biosciences.
Company Details
Feldan is developing regenerative medicine therapeutic applications based on Feldan’s proprietary technology. The company has developed Feldan Shuttle, a protein-based technology platform that directly delivers proteins – such as nucleases or transcription factors - inside cells to specific cellular compartments. The Shuttle can overcome obstacles faced by nucleic acid delivery for therapeutic use by decreasing the regulatory process and accelerating the translation of discoveries into clinical applications. The Shuttle also allows enables the development of in-house medical applications as well as in collaboration with partners.
- Website
- www.feldan.com/
- Social
- Email ID
- *****@feldan.com
- Phone Number
- +1 **********
- Registered Address
- 2577 De Miniac, St-Laurent
Key Metrics
Founded Year
2007
Location
Quebec City, Canada
Stage
Series B
Total Funding
$52.9M in 9 rounds
Latest Funding Round
Investors
Ranked
23rd among 2004 active competitors
Legal entities associated with Feldan
Feldan is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Feldan Bio Inc. CIN: 677220-0 , Canada, Active | May 15, 2007 | - | - | - |
Sign up to download Feldan's company profile
Feldan's funding and investors
Feldan has raised a total funding of $52.9M over 9 rounds. Its first funding round was on Apr 30, 2009. Its latest funding round was a Series B round on Apr 16, 2025 for $*****. 1 investor participated in its latest round. Feldan has 14 institutional investors.
Here is the list of recent funding rounds of Feldan:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 16, 2025 | 7294986 | Series B | 4579341 | 9055534 | 8101301 | 7171393 |
Feb 18, 2025 | 3352095 | Series B | 6097742 | 3739755 | 1172250 | |
Sep 04, 2024 | 8551153 | Series B | 2094802 | 3666539 | 7128541 |
Access funding benchmarks and valuations. Sign up today!View details of Feldan's funding rounds and investors
Feldan's founders and board of directors
Founder? Claim ProfileHere are the details of Feldan's key team members:
- Francois Thomas Michaud: CEO of Feldan.
Feldan's Board of Directors
Feldan's board has 7 active members. Paul F. Truex, David J Mazzo, Sandoval-little Elisabeth, François-thomas Michaud, James Stiff, Eric Gordon Carter and Nathalie Chauret are independent board members.Here is the list of Feldan's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 7y 5m | |
zenwpzw | Independent board member | - | Current | 3y 5m |
hlxiuyr | Independent board member | - | Current | 3y 9m |
bftskfe | Independent board member | - | Current | 9y 2m |
ywdolgi | Independent board member | - | Current | 6y 6m |
ovyrhcx | Independent board member | - | Current | 8y 7m |
xwlmojr | Independent board member | - | Current | 2y 7m |
View details of Feldan's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Feldan's Competitors and alternates
Top competitors of Feldan include Synthego, Sutro Biopharma and Avidity Biosciences. Here is the list of Top 10 competitors of Feldan, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
2nd | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 69/100 | |
3rd |  Avidity Biosciences 2012, San Diego (United States), Acquired | RNA therapeutics innovator targeting muscle and other diseases with AOC platform | $143M | 68/100 | |
4th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 67/100 | |
5th | Savara Pharma 2008, Austin (United States), Public | Developer of therapeutics for rare respiratory diseases | $67.8M | 67/100 | |
6th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
7th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
8th | Invenra 2011, Madison (United States), Series A | Pioneering bispecific and trispecific antibody discovery and development for novel therapies | $21.3M | 65/100 | |
9th | _1530865304957.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 65/100 | |
10th | Checkerspot 2016, Oakland (United States), Series C | Novel materials for various applications using synthetic biology | $117M | 64/100 | |
23rd | Developing delivery system of proteins inside cells directly | $52.9M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Feldan's competitors? Click here to see the top ones
Feldan's Investments and acquisitions
Feldan has made no investments or acquisitions yet.
Reports related to Feldan
Here is the latest report on Feldan's sector:
News related to Feldan
Filter this listMedia has covered Feldan for a total of 2 events in the last 1 year.
•
Feldan Therapeutics Secures Investment from Zynext VenturesFinSMEs•Apr 17, 2025•Feldan, Zynext Ventures
•
Zynext Ventures Invests in Feldan Therapeutics to Advance Intracellular Drug DeliveryPR Newswire•Apr 17, 2025•Zynext Ventures, Feldan, Zydus Life
•
•
•
•
Feldan Therapeutics Holds Initial Closing of $16.5M Series B FundingFinSMEs•Jun 14, 2023•Feldan, Invest Quebec, Amgen, GC Green Cross Lab Cell and 1 other
•
Feldan Therapeutics Awarded Funding by Cystic Fibrosis FoundationMedical Device News•Jan 18, 2022•Feldan, Cystic Fibrosis Foundation
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Feldan
Explore our recently published companies
- Juno Industries - Vancouver based, 2025 founded, Seed company
- Ryan Litfin - Eden Prairie based, 2008 founded, Seed company
- CIG Energy - Windermere based, 2025 founded, Funding Raised company
- National Commodity & Derivatives Exchange - Mumbai based, 2003 founded, Series B company
- Raj Petro Specialities - Chennai based, 1997 founded, Acquired company
- Valvoline - Lexington based, 1866 founded, Unfunded company
